4 results match your criteria: "Lille Nord-de-France University Hospital[Affiliation]"

The efficacy of intravenous immunoglobulins (IVIg) in patients with autoimmune diseases (AID) has been known for several decades. Majority of these patients received IVIg in hospital. A retrospective study was conducted in 22 centers in France to evaluate the feasibility of the administration of Tegeline, an IVIg from LFB Biomedicaments, and assess its safety at home, compared to in hospital, in patients with AID.

View Article and Find Full Text PDF

Community-acquired bone and joint infections in children: a 1-year prospective epidemiological study.

Arch Dis Child

February 2015

Lille-2 University, University of Lille Nord-de-France, Lille, France Paediatric Emergency Unit and Infectious Diseases, Lille Nord-de-France University Hospital, CHRU Lille, Lille, France EA 2694, Public Health: Epidemiology and Quality of Care, University of Lille-Nord-de-France, Lille, France.

Background: The incidence of childhood bone and joint infections (BJIs) is not well known, but is useful for identifying epidemiological differences and improving practice.

Objective: To determine the incidence of BJI in previously well children and describe their clinical, laboratory and radiological characteristics.

Design: A multicentre, population-based, prospective study performed from July 2008 through June 2009.

View Article and Find Full Text PDF

Background: The prognosis of febrile neutropenia (FN) in childhood cancer has been considerably improved by the intensification of treatment, including systematic hospitalization and broad-spectrum antibiotics. As only few children present with a severe bacterial infection (SBI), clinical decision rules have been developed to distinguish those at risk for SBI. The aim of this study was to evaluate the reproducibility of six clinical decision rules proposed in the literature and to compare their performance.

View Article and Find Full Text PDF